Fat-soluble injection
An injection and fat-dissolving technology, applied in the field of medicine, can solve the problems of many postoperative complications, high surgical risk, severe pain, etc., and achieve the effects of fast recovery, low risk and light pain.
Inactive Publication Date: 2020-01-31
SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF5 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0009] The invention solves the problems of high surgical risk, severe pain, many postoperative complications and slow recovery caused by the removal of local fat accumulation in the prior art
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0048] An alisol A fat-dissolving injection, the concentration of alisol A is 0.0098mg / ml. The ingredients of the fat-dissolving injection are alisol A, cremophor EL, ethanol, and dd water.
Embodiment 2
[0050] An alisol A fat-dissolving injection, the concentration of alisol A is 10 mg / ml. The ingredients of the fat-dissolving injection are alisol A, cremophor EL, ethanol, and dd water.
Embodiment 3
[0052] An alisol A fat-dissolving injection, the concentration of alisol A is 6mg / ml. The preparation process is as follows:
[0053] Add 0.5ml of cremophor EL to 90mg of alisitol A, add 1.0ml of ethanol to 15ml of dd water and stir evenly.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The present invention provides a fat-soluble injection. A main component of the fat-soluble injection is alisol A. The fat-soluble injection acts on sites where local fat accumulates. For the first time, the alisol A is proposed to be injected directly into subcutaneous fat and used as the fat-soluble injection. Compared with fat-soluble injection on the market, the fat-soluble injection is saferand less in side effects. Compared with traditional liposuction surgery, patients are less in pains, risks are lower, operations are simple, recovery after surgery is quick, and the fat-soluble injection has unparalleled advantages in a local obesity treatment.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a fat-dissolving injection. Background technique [0002] With the development of society, the number of obese people in the world is increasing rapidly. The impact of local fat accumulation in the body on health and aesthetics has become one of the key research directions of medical scientists from all over the world. The fat-dissolving injection that came into being refers to injecting drugs directly into the subcutaneous fat layer of the human body to dissolve the fat. The US Food and Drug Administration (FDA) approved the world’s first fat-dissolving injection, kybella, in 2015, which is suitable for patients with moderate And adults with severe "double chin". At present, in my country, there is no fat-dissolving injection approved by the national drug supervision and management department. [0003] The fat-dissolving injections currently on the market have not been effectively sup...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/575A61K47/10A61P3/04A61P3/06
CPCA61K9/0021A61K9/08A61K31/575A61K47/10A61P3/04A61P3/06
Inventor 侯家康张艺凡高雅李青峰
Owner SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
